It has attracted huge interest because it involves active glucagon-like peptide-1 (GLP-1), an incretin which potentiates insulin secretion and has been shown to increase proliferation and decrease apoptosis of the pancreatic beta cells[45], and which presents great therapeutic potential for the treatment of T2D[46]. Here, GCG is linked to type 2 diabetes mellitus.